|
1
|
Ruicci KM, Meens J, Sun RX, Rizzo G, Pinto
N, Yoo J, Fung K, MacNeil D, Mymryk JS, Barrett JW, et al: A
controlled trial of HNSCC patient-derived xenografts reveals broad
efficacy of PI3Kα inhibition in controlling tumor growth. Int J
Cancer. 145:2100–2106. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Khurshid Z, Zafar MS, Khan RS, Najeeb S,
Slowey PD and Rehman IU: Role of salivary biomarkers in oral cancer
detection. Adv Clin Chem. 86:23–70. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thomson PJ: Perspectives on oral squamous
cell carcinoma prevention-proliferation, position, progression and
prediction. J Oral Pathol Med. 47:803–807. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sim F, Leidner R and Bell RB:
Immunotherapy for Head and Neck cancer. Oral Maxillofac Surg Clin
North Am. 31:85–100. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yao Y, Chen X, Lu S, Zhou C, Xu G, Yan Z,
Yang J, Yu T, Chen W, Qian Y, et al: Circulating long noncoding
rnas as biomarkers for predicting head and neck squamous cell
carcinoma. Cell Physiol Biochem. 50:1429–1440. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Long T, Liu Z, Zhou X, Yu S, Tian H and
Bao Y: Identification of differentially expressed genes and
enriched pathways in lung cancer using bioinformatics analysis. Mol
Med Rep. 19:2020–2040. 2019.
|
|
7
|
Lei B, Zhang XY, Zhou JP, Mu GN, Li YW,
Zhang YX and Pang D: Transcriptome sequencing of HER2-positive
breast cancer stem cells identifies potential prognostic marker.
Tumour Biol. 37:14757–14764. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu L, Guo Q, Jin S, Feng H, Zhuang H, Liu
C, Tan M, Liu J, Li X and Lin B: Analysis of the gene expression
profile in response to human epididymis protein 4 in epithelial
ovarian cancer cells. Oncol Rep. 36:1592–1604. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xie C, Xu M, Lu D, Zhang W, Wang L, Wang
H, Li J, Ren F and Wang C: Candidate genes and microRNAs for glioma
pathogenesis and prognosis based on gene expression profiles. Mol
Med Rep. 18:2715–2723. 2018.PubMed/NCBI
|
|
10
|
Chen Y, Hennessy KM, Botstein D and Tye
BK: CDC46/MCM5, a yeast protein whose subcellular localization is
cell cycle-regulated, is involved in DNA replication at
autonomously replicating sequences. Proc Natl Acad Sci USA.
89:10459–10463. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Su Z, Zheng X, Zhang X, Wang Y, Zhu S, Lu
F, Qu J and Hou L: Sox10 regulates skin melanocyte proliferation by
activating the DNA replication licensing factor MCM5. J Dermatol
Sci. 85:216–225. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhong H, Chen B, Neves H, Xing J, Ye Y,
Lin Y, Zhuang G, Zhang SD, Huang J and Kwok HF: Expression of
minichromosome maintenance genes in renal cell carcinoma. Cancer
Manag Res. 9:637–647. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liao X, Han C, Wang X, Huang K, Yu T, Yang
C, Huang R, Liu Z, Han Q and Peng T: Prognostic value of
minichromosome maintenance mRNA expression in early-stage
pancreatic ductal adenocarcinoma patients after
pancreaticoduodenectomy. Cancer Manag Res. 10:3255–3271. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang D, Li Q, Li Y and Wang H: The role of
MCM5 expression in cervical cancer: Correlation with progression
and prognosis. Biomed Pharmacother. 98:165–172. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu H, Takeuchi S, Moroi Y, Lin N, Urabe
K, Kokuba H, Imafuku S, Dainichi T, Uchi H, Furue M and Tu Y:
Expression of minichromosome maintenance 5 protein in proliferative
and malignant skin diseases. Int J Dermatol. 46:1171–1176. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liao X, Liu X, Yang C, Wang X, Yu T, Han
C, Huang K, Zhu G, Su H, Qin W, et al: Distinct diagnostic and
prognostic values of minichromosome maintenance gene expression in
patients with hepatocellular carcinoma. J Cancer. 9:2357–2373.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu SY, Wang YP, Chang JY, Shen WR, Chen HM
and Chiang CP: Increased expression of MCM5 is significantly
associated with aggressive progression and poor prognosis of oral
squamous cell carcinoma. J Oral Pathol Med. 43:344–349. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jia CY, Li HH, Zhu XC, Dong YW, Fu D, Zhao
QL, Wu W and Wu XZ: MiR-223 suppresses cell proliferation by
targeting IGF-1R. PLoS One. 6:e270082011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Saleem M, Asif J, Asif M and Saleem U:
Amygdalin from apricot kernels induces apoptosis and causes cell
cycle arrest in cancer cells: An updated review. Anticancer Agents
Med Chem. 18:1650–1655. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Seo YS and Kang YH: The Human replicative
helicase, the CMG Complex, as a target for anti-cancer therapy.
Front Mol Biosci. 5:262018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Everson M, Magee C, Alzoubaidi D, Brogden
S, Graham D, Lovat LB, Novelli M and Haidry R: Minichromosomal
maintenance component complex 5 (MCM5) as a marker of barrett's
esophagus-related neoplasia: A feasibility study. Dig Dis Sci.
64:2815–2822. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Margalit DN and Lin A: Two sides of the
same coin: Head and neck cancer treatment De-Intensification and
intensification with induction chemotherapy. Int J Radiat Oncol
Biol Phys. 102:1–4. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mio C, Lavarone E, Conzatti K, Baldan F,
Toffoletto B, Puppin C, Filetti S, Durante C, Russo D, Orlacchio A,
et al: MCM5 as a target of BET inhibitors in thyroid cancer cells.
Endocr Relat Cancer. 23:335–347. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gakiopoulou H, Korkolopoulou P, Levidou G,
Thymara I, Saetta A, Piperi C, Givalos N, Vassilopoulos I, Ventouri
K, Tsenga A, et al: Minichromosome maintenance proteins 2 and 5 in
non-benign epithelial ovarian tumours: Relationship with cell cycle
regulators and prognostic implications. Br J Cancer. 97:1124–1134.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kelly JD, Dudderidge TJ, Wollenschlaeger
A, Okoturo O, Burling K, Tulloch F, Halsall I, Prevost T, Prevost
AT, Vasconcelos JC, et al: Bladder cancer diagnosis and
identification of clinically significant disease by combined
urinary detection of Mcm5 and nuclear matrix protein 22. PLoS One.
7:e403052012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen X, Scapa JE, Liu DX and Godbey WT:
Cancer-specific promoters for expression-targeted gene therapy:
Ran, brms1 and mcm5. J Gene Med. 18:89–101. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang D, Wang H, Li Y and Li Q: MiR-362-3p
functions as a tumor suppressor through targeting MCM5 in cervical
adenocarcinoma. Biosci Rep. 38:BSR201806682018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Janardhan K, Jensen H, Clayton NP and
Herbert RA: Immunohistochemistry in investigative and toxicologic
pathology. Toxicol Pathol. 46:488–510. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hua C, Zhao G, Li Y and Bie L:
Minichromosome maintenance (MCM) Family as potential diagnostic and
prognostic tumor markers for human gliomas. BMC Cancer. 14:5262014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Majid S, Dar AA, Saini S, Chen Y,
Shahryari V, Liu J, Zaman MS, Hirata H, Yamamura S, Ueno K, et al:
Regulation of minichromosome maintenance gene family by
microRNA-1296 and genistein in prostate cancer. Cancer Res.
70:2809–2818. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Das M, Prasad SB, Yadav SS, Govardhan HB,
Pandey LK, Singh S, Pradhan S and Narayan G: Over expression of
minichromosome maintenance genes is clinically correlated to
cervical carcinogenesis. PLoS One. 8:e696072013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Issac MSM, Yousef E, Tahir MR and Gaboury
LA: MCM2, MCM4, and MCM6 in breast cancer: Clinical utility in
diagnosis and prognosis. Neoplasia. 21:1015–1035. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Giaginis C, Georgiadou M, Dimakopoulou K,
Tsourouflis G, Gatzidou E, Kouraklis G and Theocharis S: Clinical
significance of MCM-2 and MCM-5 expression in colon cancer:
Association with clinicopathological parameters and tumor
proliferative capacity. Dig Dis Sci. 54:282–291. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu YZ, Wang BS, Jiang YY, Cao J, Hao JJ,
Zhang Y, Xu X, Cai Y and Wang MR: MCMs expression in lung cancer:
Implication of prognostic significance. J Cancer. 8:3641–3647.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Korkolopoulou P, Givalos N, Saetta A,
Goudopoulou A, Gakiopoulou H, Thymara I, Thomas-Tsagli E and
Patsouris E: Minichromosome maintenance proteins 2 and 5 expression
in muscle-invasive urothelial cancer: A multivariate survival study
including proliferation markers and cell cycle regulators. Hum
Pathol. 36:899–907. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Passerini V, Ozeri-Galai E, de Pagter MS,
Donnelly N, Schmalbrock S, Kloosterman WP, Kerem B and Storchová Z:
The presence of extra chromosomes leads to genomic instability. Nat
Commun. 7:107542016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Aparicio T, Guillou E, Coloma J, Montoya G
and Méndez J: The human GINS complex associates with Cdc45 and MCM
and is essential for DNA replication. Nucleic Acids Res.
37:2087–2095. 2009. View Article : Google Scholar : PubMed/NCBIPubMed/NCBIPubMed/NCBIPubMed/NCBI
|
